JackBBasilMD

Obstetrics & Gynecology • Cincinnati, OH

Gynecologic Oncology

Chairman Department of Obstetrics and Gynecology Trihealth, Medical Director of Trihealth Women's Institute

Join to view full profile

Dr. Basil is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Basil's full profile

Already have an account?

Office
3219 Clifton Ave
Suite 100
Cincinnati, OH 45220
Phone+1 513-862-1888

Fax+1 513-862-3616
Is this information wrong?

Education & Training

Washington University/B-JH/SLCH ConsortiumResidency, Obstetrics and Gynecology, 1993 - 1997
Ohio State University College of MedicineClass of 1993

Certifications & Licensure

KY State Medical License 2004 - 2024
OH State Medical License 2004 - 2023
FL State Medical License 2014 - 2016
GA State Medical License 2000 - 2005
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Fellow (FACS) American College of Surgeons

Clinical Trials

Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer Start of enrollment: 2008 Mar 10
Completed
Phase 2
Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer Start of enrollment: 2008 Feb 25
Active, not recruiting
Phase 2
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18
Recruiting
Phase 3
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer Start of enrollment: 2009 Apr 01
Completed
Phase 3
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Start of enrollment: 2009 Mar 23
Active, not recruiting
Phase 3
Collecting Tumor Samples From Patients With Gynecological Tumors Start of enrollment: 1992 Jun 01
Completed
YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving Chemotherapy Start of enrollment: 2007 Sep 01
Terminated
Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer Start of enrollment: 2010 Oct 12
Active, not recruiting
Phase 3
Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Start of enrollment: 2011 Aug 15
Active, not recruiting
Join now to see all

Publications & Presentations

PubMed

Patient perspectives of telemedicine in gynecologic oncology during COVID.
Christina Nestlerode, James Pavelka, Jack Basil, Kevin Schuler, Angela N Fellner, Mostafa Ghaderian, Robert Neff> ;Gynecologic Oncology Reports. 2022 Oct 1
3 citations
Randomized Controlled Phase II Evaluation of Two Dose Levels of Bupropion Versus Placebo for Sexual Desire in Female Cancer Survivors: NRG-CC004.
Debra L Barton, Stephanie L Pugh, Patricia A Ganz, Steven C Plaxe, Bridget F Koontz, Jeanne Carter, Natalya Greyz-Yusupov, Seth J Page, Kendrith M Rowland Jr, Ernie P ...> ;Journal of Clinical Oncology. 2022 Feb 1
1 citations
Chlorhexidine Versus Iodine for Vaginal Preparation Before Hysterectomy: A Randomized Clinical Trial.
Austin M Hill, Rachel N. Pauls, Jack B. Basil, Tiffanie Tam, Eunsun Yook, Abigail Shatkin-Margolis, Steven D. Kleeman, Jennifer Yeung, Emily R Aldrich, Catrina C. Crisp> ;Female pelvic medicine & reconstructive surgery. 2021 Jul 29
1 citations
Somatic Tumor Profile Analysis in a Patient with Germline PMS2 Mutation and Synchronous Ovarian and Uterine Carcinomas.
Karen M Huelsman, Jack B Basil, Rebecca Sisson, Lindsay R Lipe, Brett Mahon, David J Draper> ;Journal of Personalized Medicine. 2021 Jul 5
297 citations
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.
Timothy R. Rebbeck, Nandita Mitra, Fei Wan, Olga M. Sinilnikova, Sue Healey, Lesley McGuffog, Sylvie Mazoyer, Georgia Chenevix-Trench, Douglas F. Easton, Antonis C. An...> ;JAMA. 2015 Apr 7
36 citations
Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers
Fergus J. Couch, Mia M. Gaudet, Antonis C. Antoniou, Susan J. Ramus, Karoline Kuchenbaecker, Penny Soucy, Jonathan Beesley, Xiaoqing Chen, Xianshu Wang, Tomas Kirchhof...> ;Cancer Epidemiology, Biomarkers & Prevention. 2012 Apr 1
16 citations
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers
David G. Cox, Jacques Simard, Daniel Sinnett, Yosr Hamdi, Penny Soucy, Manon Ouimet, Laure Barjhoux, Carole Verny-Pierre, Lesley McGuffog, Sue Healey, Csilla Szabo, Ma...> ;Human Molecular Genetics. 2011 Dec 1
56 citations
Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers
Antonis C. Antoniou, Christiana Kartsonaki, Olga M. Sinilnikova, Penny Soucy, Lesley McGuffog, Sue Healey, Andrew Lee, Paolo Peterlongo, Siranoush Manoukian, Bernard P...> ;Human Molecular Genetics. 2011 Aug 15
139 citations
Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction
Antonis C. Antoniou, Jonathan Beesley, Lesley McGuffog, Olga M. Sinilnikova, Sue Healey, Susan L. Neuhausen, Yuan Chun Ding, Timothy R. Rebbeck, Jeffrey N. Weitzel, He...> ;Cancer Research. 2010 Dec 1
256 citations
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population
Antonis C. Antoniou, Xianshu Wang, Zachary S. Fredericksen, Lesley McGuffog, Robert F. Tarrell, Olga M. Sinilnikova, Sue Healey, Jonathan J. Morrison, Christiana Karts...> ;Nature Genetics. 2010 Oct 1
1 citations
Placental site trophoblastic tumor presenting as an intramural mass with negative markers: an opportunity for novel diagnosis and treatment with robotic hysterectomy
Devin Namaky, Jack Basil, James Pavelka> ;Journal of Robotic Surgery. 2010 Mar 18
11 citations
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators o...
Ana Osorio, Roger L. Milne, Guillermo Pita, Paolo Peterlongo, Tuomas Heikkinen, Jacques Simard, Georgia Chenevix-Trench, Amanda B. Spurdle, Jonathan Beesley, Xiaoqing ...> ;British Journal of Cancer. 2009 Dec 8
84 citations
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers
Antonis C. Antoniou, Olga M. Sinilnikova, Lesley McGuffog, Sue Healey, Heli Nevanlinna, Tuomas Heikkinen, Jacques Simard, Amanda B. Spurdle, Jonathan Beesley, Xiaoqing...> ;Human Molecular Genetics. 2009 Nov 15
71 citations
A Prospective Study of Risk-Reducing Salpingo-oophorectomy and Longitudinal CA-125 Screening among Women at Increased Genetic Risk of Ovarian Cancer: Design and Baseli...
Mark H. Greene, Marion Piedmonte, D.S. Alberts, Mitchell H. Gail, Martee L. Hensley, Zoe Miner, Phuong L. Mai, Jennifer T. Loud, Gustavo C. Rodriguez, Jack Basil, John...> ;Cancer Epidemiology, Biomarkers & Prevention. 2008 Mar 1
19 citations
Predictors of cervical dysplasia after the loop electrosurgical excision procedure in an inner-city population.
Robin H Fogle, Cyril O Spann, Kirk A. Easley, Jack B Basil> ;Journal of Reproductive Medicine. 2004 Jun 1
3 citations
Cervical carcinoma: contemporary management.
Jack B. Basil, Ira R. Horowitz> ;Obstetrics and Gynecology Clinics of North America. 2001 Dec 1
1 citations
Role of hormone replacement therapy in cancer survivors.
Jack B. Basil, David G. Mutch> ;Clinical Obstetrics and Gynecology. 2001 Sep 1
91 citations
Clinical significance of microsatellite instability in endometrial carcinoma.
Jack B. Basil, Paul J. Goodfellow, Janet S. Rader, David G. Mutch, Thomas J. Herzog> ;Cancer. 2000 Oct 15
24 citations
Absence of PTEN Repeat Tract Mutation in Endometrial Cancers with Microsatellite Instability
David E. Cohn, Jack B. Basil, Anna R Venegoni, David G. Mutch, Janet S. Rader, Thomas J. Herzog, Deborah J. Gersell, Paul J. Goodfellow> ;Gynecologic Oncology. 2000 Oct 1
Management of women at risk for malignancy
Jack B. Basil, Janet S. Rader> ;Current Opinion in Oncology. 2000 Sep 1
10 citations
Mutational analysis of the PMS2 gene in sporadic endometrial cancers with microsatellite instability.
Jack B. Basil, Elizabeth M. Swisher, Thomas J. Herzog, Janet S. Rader, Alaa Elbendary, David G. Mutch, Paul J. Goodfellow> ;Gynecologic Oncology. 1999 Sep 1
4 citations
Recurrent ovarian tumor with low malignant potential and cardiac metastasis.
Jack B. Basil, Edward R. Kost, Thomas J. Herzog, Kevin M. Harris, Helen Liapis, David C. Mutch> ;Obstetrics & Gynecology. 1997 May 1
13 citations
Antenatal steroids and intraventricular hemorrhage after premature rupture of membranes at 24-28 weeks' gestation.
Bruce Chen, Jack Basil, Georgia Schefft, F. S. Cole, Yoel Sadovsky> ;American Journal of Perinatology. 1997 Mar 1
5 citations
Microbial biotransformation of retinoic acid by Cunninghamella echinulata and Cunninghamella blakesleeana.
David A. Hartman, Jack Basil, Larry W. Robertson, Robert W. Curley> ;Pharmaceutical Research. 1990 Mar 1
Join now to see all